Zahra Yousefi

Given the increasing importance of recognition in academia and the vital role of randomised controlled trials (RCTs) in medical research and clinical decisions, this study verifies how RCTs’ academic and societal impacts are affected by visibility factors, subjects and methodological validity. This study concentrated on a sample of 446 RCTs indexed in Scopus and evaluated by Cochrane reviewers in terms of their methodological validity. The altmetrics, bibliometric and bibliographical information were extracted from Altmetric.com and Scopus, and the contributing countries’ development ranks were obtained from the United Nations Development report. The linear regression analyses revealed that citations and altmetrics depend on some subjects. They are also affected by publication year and journals’ previous reputation. Citations are also affected by keyword counts and reference counts. Keyword counts and contributing countries’ developmental rank also predict the tweet counts. While none of the methodological validity dimensions were found to predict citations, ‘Incomplete Outcome Data’ and ‘Random Sequence Generation’ significantly, though slightly, affect Mendeley Readership and tweets, respectively. By confirming the dependence of RCTs’ recognition on some methodological validity features and attention-inducing characteristics, the study provides further evidence on the interaction of quality and visibility dynamisms in the recognition network and the complementary role of societal mentions for academic citation.